Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin vs gliclazide as add-on to metformin during Ramadan fasting in Muslim patients with type 2 diabetes
2011-005499-41Phase 4Terminated
- Sponsor
- Novartis
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vildagliptin + metformin with Gliclazide + metformin (2 arms). Primary endpoint: Proportion of patients experiencing at least one hypoglycaemic event during Ramadan fasting. Started Oct 2012; status: terminated.
02
Drugs
vildagliptingliclazidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-005499-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005499-41.